Reducing the incidence and effects of malaria in Kenya.
Who Are We? Sisi ni akina nani?
NoMAK, which stands for ‘NO MALARIA KENYA’, is a Kenyan corporation with Kenyan board members. It was founded by the principals of Kleenhealth Australia and hunterPac Global, whose main focus is reducing the incidence and effects of malaria with the help of MOZZi.
Dangers Posed by Malaria in Kenya
Malaria is the leading cause of morbidity and mortality in Kenya.
Malaria accounts for 30-50% of all outpatient attendance and 20% of all admissions to health facilities.
170 million estimated working days are lost to malaria each year (MOH, 2001).
Malaria is also estimated to cause 20% of all deaths in children under the age of 5 years.
What We Offer
Stopping Malaria & Empowering Kenya.
NoMAK manufactures MOZZi, Australian products which have been tried and tested to be of use in any household, to service the Northern and Eastern countries of Africa economically and with expedience utilising like-minded and like-cultured professionals. NOMAK is here to fight Malaria in Kenya. This is in line with Ministry of Health Malaria eradication program.
NoMAK Helping Implement the Government’s Agenda.
Kenya has committed to beating malaria in the country, the Commonwealth and beyond. Reducing Malaria will improve the management of primary healthcare and enable Kenya to make significant strides in delivering universal healthcare. NoMAK’s objective with the MOZZi product is in line with this initiative and is ready to fulfil this as an additional tool to boost the fight against Malaria.
Learn More About Mozzi
